Prevalence of chronic renal disease in Spain: results of the EPIRCE study - PubMed (original) (raw)
Prevalence of chronic renal disease in Spain: results of the EPIRCE study
Alfonso Otero et al. Nefrologia. 2010.
Free article
Abstract
Introduction: Chronic kidney disease (CKD) is an independent cardiovascular risk factor. The knowledge of prevalence in general population may help to early detection of CKD and prevent or delay its progression.
Methods: Sociodemographic, baseline characteristics, and CKD prevalence (measured by centralized serum creatinine and MDRD equation) were evaluated in a randomly selected sample of general population aged 20 years or older, collected in all Spanish regions and stratified by habitat, age and sex according to 2001 census (n=2746). Univariate and multivariate logistic regression analyses were used to evaluate associations with CKD risk factors.
Results: Mean age was 49.5 years. The overall prevalence of Kidney Disease Outcomes Quality Initiative grades 3-5 CKD was 6.8%, with a 95% confidence interval (CI) of 5.4 to 8.2 (3.3% for age 40-64 years and 21.4% for age > 64 years). The prevalence estimates of CKD stages were: 0.99% for stage 1 (glomerular filtration rate [GFR] >or=90 ml/min per 1.73 m2 with proteinuria); 1.3% for stage 2 (GFR 60-89); 5.4% for stage 3a (GFR 45-59); 1.1% for stage 3b (GFR 30-44); 0.27% for stage 4 (GFR 15-29); and 0.03% for stage 5 (GFR < 15). An important prevalence of classical cardiovascular risk factors was observed: dyslipemia (29.3%), obesity (26.1%), hypertension (24.1%), diabetes (9.2%) and current smoking (25.5%). The independent predictor factors for CKD were age, obesity and previously diagnosed hypertension.
Conclusion: The prevalence of CKD at any stage in general population from Spain is relatively high, especially in the elderly, and similar to countries of the same geographical area. Independently of age, two modifiable risks factors, hypertension and obesity, are associated with an increased prevalence of CKD.
Similar articles
- Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
Ando M, Ohashi K, Akiyama H, Sakamaki H, Morito T, Tsuchiya K, Nitta K. Ando M, et al. Nephrol Dial Transplant. 2010 Jan;25(1):278-82. doi: 10.1093/ndt/gfp485. Epub 2009 Sep 17. Nephrol Dial Transplant. 2010. PMID: 19762604 - [Epidemiology of CKD in Japan].
Iseki K. Iseki K. Nihon Rinsho. 2008 Sep;66(9):1650-6. Nihon Rinsho. 2008. PMID: 18788390 Review. Japanese. - The conundrum of chronic kidney disease classification and end-stage renal risk prediction in the elderly--what is the right approach?
Hallan SI, Orth SR. Hallan SI, et al. Nephron Clin Pract. 2010;116(4):c307-16. doi: 10.1159/000319166. Epub 2010 Jul 24. Nephron Clin Pract. 2010. PMID: 20664285 Review.
Cited by
- NSAIDs, analgesics, antiplatelet drugs, and decline in renal function: a retrospective case-control study with SIDIAP database.
Bonet-Monné S, Urgell CV, Sáez MJP, Puertolás OC, Baena-Díez JM, Pascual J, Lago CO, Ruiz JR, Gonzalez BS, Pedrós RM. Bonet-Monné S, et al. BMC Pharmacol Toxicol. 2024 Aug 28;25(1):58. doi: 10.1186/s40360-024-00771-5. BMC Pharmacol Toxicol. 2024. PMID: 39198874 Free PMC article. - Enhancing Kidney Transplant Outcomes: The Impact of Living Donor Programs.
Noya-Mourullo A, Martín-Parada A, Palacios-Hernández A, Eguiluz-Lumbreras P, Heredero-Zorzo Ó, García-Gómez F, Álvarez-Ossorio-Fernández JL, Álvarez-Ossorio-Rodal A, Márquez-Sánchez MT, Flores-Fraile J, Fraile-Gómez P, Padilla-Fernández BY, Lorenzo-Gómez MF. Noya-Mourullo A, et al. J Pers Med. 2024 Apr 12;14(4):408. doi: 10.3390/jpm14040408. J Pers Med. 2024. PMID: 38673035 Free PMC article. - Living normally without being oneself: A qualitative study on the experience of living with advanced chronic kidney disease.
de la Cuesta-Benjumea C, Hernádez-Ibarra LE, Arredondo-González CP. de la Cuesta-Benjumea C, et al. PLoS One. 2023 Dec 21;18(12):e0295506. doi: 10.1371/journal.pone.0295506. eCollection 2023. PLoS One. 2023. PMID: 38128051 Free PMC article. - Differences in the epidemiology, management and outcomes of kidney disease in men and women.
Chesnaye NC, Carrero JJ, Hecking M, Jager KJ. Chesnaye NC, et al. Nat Rev Nephrol. 2024 Jan;20(1):7-20. doi: 10.1038/s41581-023-00784-z. Epub 2023 Nov 20. Nat Rev Nephrol. 2024. PMID: 37985869 Review. - A study of crystalluria: effectiveness of including hygienic-dietary recommendations in laboratory reports.
Sienes Bailo P, Santamaría González M, Izquierdo Álvarez S, Lahoz Alonso R, Serrano Frago P, Bancalero Flores JL. Sienes Bailo P, et al. Adv Lab Med. 2021 Feb 10;2(1):109-120. doi: 10.1515/almed-2020-0124. eCollection 2021 Mar. Adv Lab Med. 2021. PMID: 37359207 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical